Solaxa
Bethesda, US · Founded 2021 · Delaware corporation · 2 known investors
Solaxa is a biotech company developing pharmacological and cell-based treatments for peripheral nerve injury and spinal cord injury, drawing on regenerative medicine and nerve technologies. It focuses on drug and drug-device combination products in the field of neurology.
Founders & leadership
Solaxa was founded in 2021 by Mark Noble.
MN
Mark NobleChief Science Officer & Co-Founder
CW
Christian WalkerPresident, Chief Development Officer & Founder
BP
Bill PasserChief Financial Officer
BN
Brad NaviaChief Medical Officer
Board
LG
Luis GutierrezBoard director
LS
Lauren SabellaBoard director
Investors · 2
Competitors · 2
by search overlapCybrexa, Inc.11 shared keywordsCybrexa is a biotechnology company developing cancer therapeutics that use its alphalex peptide-drug conjugate platform to target the low-pH tumor microenvironment for selective delivery. The technology aims to enable more potent drugs and combination therapies and to expand the efficacy of existing anticancer agents.
Exelixis7 shared keywordsExelixis is a biopharmaceutical company developing cancer therapies through biotherapeutics and small molecule programs, including bispecific antibodies and antibody-drug conjugates. It advances anti-cancer treatments internally and via industry collaborations across multiple modalities in biologics and small molecules.
Companies competing with Solaxa for the same Google search keywords, organic and paid, via search-intersection analysis.
Reported raises · per SEC filings
Form D private placements$1.9M disclosed across 4 rounds · 2021–2024
▶$305KraisedSep 2024 · 4 investors · PharmaceuticalsRule 506(b)
▶$305KraisedSep 2024 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Luis GutierrezDirector
- Lauren SabellaDirector
- Christian WalkerExecutive Officer, Director
- Offering amount
- $6M
- Amount sold
- $305K
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$500KraisedMay 2024 · 1 investors · PharmaceuticalsRule 506(b)
▶$500KraisedMay 2024 · 1 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Lauren SabellaDirector
- Christian WalkerExecutive Officer, Director
- Luis GutierrrezExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$729KraisedMay 2024 · 13 investors · PharmaceuticalsRule 506(b)
▶$729KraisedMay 2024 · 13 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Christian WalkerExecutive Officer, Director
- Lauren SabellaDirector
- Luis GutierrezExecutive Officer, Director
- Offering amount
- $729K
- Amount sold
- $729K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$365KraisedMay 2024 · 8 investors · PharmaceuticalsRule 506(b)
▶$365KraisedMay 2024 · 8 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Luis GutierrezExecutive Officer, Director
- Christian WalkerExecutive Officer, Director
- Lauren SabellaDirector
- Offering amount
- $2.1M
- Amount sold
- $365K
- First sale
- Apr 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Solaxa do?
- Solaxa is a biotech company developing pharmacological and cell-based treatments for peripheral nerve injury and spinal cord injury, drawing on regenerative medicine and nerve technologies. It focuses on drug and drug-device combination products in the field of neurology.
- Who founded Solaxa?
- Solaxa was founded by Mark Noble in 2021.
- Who are Solaxa's investors?
- Solaxa's investors include Maryland TEDCO, TEDCO.
- How much funding has Solaxa raised?
- Solaxa has disclosed $1.9M raised across 4 rounds.
- Where is Solaxa headquartered?
- Solaxa is headquartered in Bethesda, US.